C07D311/16

Water soluble 3-ketocoumarins

The present invention relates to novel 3-ketocoumarins with improved water compatibility, which are useful as photoinitiators and to compositions comprising said photoinitiators. The invention also relates to compositions comprising said novel 3-ketocoumarins and to a process for photopolymerizing comprising them.

Non-Aqueous Electrolyte Comprising Additive for Non-Aqueous Electrolyte, and Lithium Secondary Battery Comprising the Same

The present disclosure provides a non-aqueous electrolyte including an additive for a non-aqueous electrolyte, which is represented by the following Chemical Formula 1:

##STR00001##

In Chemical Formula 1, R.sub.1 to R.sub.5 are each independently any one selected from the group consisting of H, an alkyl group having 1 to 10 carbon atoms, and an alkoxy group having 1 to 10 carbon atoms, and R may be an aliphatic unsaturated hydrocarbon group having 2 to 10 carbon atoms, or —OR′ (R′ is an aliphatic unsaturated hydrocarbon group having 2 to 10 carbon atoms).

Non-Aqueous Electrolyte Comprising Additive for Non-Aqueous Electrolyte, and Lithium Secondary Battery Comprising the Same

The present disclosure provides a non-aqueous electrolyte including an additive for a non-aqueous electrolyte, which is represented by the following Chemical Formula 1:

##STR00001##

In Chemical Formula 1, R.sub.1 to R.sub.5 are each independently any one selected from the group consisting of H, an alkyl group having 1 to 10 carbon atoms, and an alkoxy group having 1 to 10 carbon atoms, and R may be an aliphatic unsaturated hydrocarbon group having 2 to 10 carbon atoms, or —OR′ (R′ is an aliphatic unsaturated hydrocarbon group having 2 to 10 carbon atoms).

3-ketocoumarins, a process for their preparation and their use as photoinitiators in photopolymerization reactions

Subject-matter of the present invention are novel 3-ketocoumarins, a process for their preparation and their use as photoinitiators in photopolymerization reactions, advantageously in photopolymerization reactions for inkjet printing inks. The invention also concerns a process for the photopolymerization of compositions also comprising said 3-ketocoumarins.

3-ketocoumarins, a process for their preparation and their use as photoinitiators in photopolymerization reactions

Subject-matter of the present invention are novel 3-ketocoumarins, a process for their preparation and their use as photoinitiators in photopolymerization reactions, advantageously in photopolymerization reactions for inkjet printing inks. The invention also concerns a process for the photopolymerization of compositions also comprising said 3-ketocoumarins.

Highly efficient free radical photopolymerizations through enabled dark cure

A quaternary ammonium salt comprising a chromophore constituent, a tertiary amine cation constituent connected to the para-position of the chromophore constituent via a methylene linkage, and a borate anion constituent, wherein chromophore constituent is a 3-ketocoumarin constituent or a benzophenone constituent. Also, a photobase-redox initiating system comprising the quaternary ammonium salt and a peroxide.

Highly efficient free radical photopolymerizations through enabled dark cure

A quaternary ammonium salt comprising a chromophore constituent, a tertiary amine cation constituent connected to the para-position of the chromophore constituent via a methylene linkage, and a borate anion constituent, wherein chromophore constituent is a 3-ketocoumarin constituent or a benzophenone constituent. Also, a photobase-redox initiating system comprising the quaternary ammonium salt and a peroxide.

MEK INHIBITORS AND THERAPEUTIC USES THEREOF

The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developing, producing and preparing compounds represented by general Formula (I), including pharmaceutically acceptable salts thereof or a synthetic intermediate thereof:

##STR00001##

The compounds act as MEK inhibitors and are capable of displaying one or more beneficial therapeutic effects, including treating cancer.

COMPOUNDS SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF MUSCLE WASTING AND OTHER CONDITIONS
20220324852 · 2022-10-13 ·

The present invention relates to a compound of the general formula I and the pharmaceutically acceptable salts thereof; where the variables are as defined in the claims and the description. The invention also relates to the compounds of formula I for use in the treatment or prophylaxis of muscle wasting conditions, of skeletal or cardial muscle atrophy, of conditions, in particular of myopathies, which are associated with an increased Muscle RING Finger 1 (MuRF1) expression and of other conditions; to the compounds of formula I for use as a medicament; to a pharmaceutical composition comprising at least one compound of formula I and to a method for treating said conditions.

##STR00001##

METHOD FOR PREPARING COUMARIN COMPOUNDS SUBSTITUTED BY AMIDOALKYL AT 3-POSITION, THE PRODUCTS AND RELATED INTERMEDIATES THEREOF
20230067666 · 2023-03-02 ·

The present invention relates to a method for preparing coumarin compounds substituted by amidoalkyl at 3-position, and related intermediates thereof. The method includes: Step (A): reacting a compound of formula (VI) with a compound of formula (V) to give a compound of formula (VII)

##STR00001## wherein R.sub.1 and R.sub.2 are each independently selected from hydrogen, halogen, and —O(C.sub.1-8 alkyl), wherein the alkyl is optionally substituted with 1 or 2 groups selected from the group consisting of halogen, C.sub.1-8 alkyl substituted with 1-2 hydroxyl groups, —O(C.sub.1-8 alkyl); R.sub.3 is -L-C(O)NR.sub.5R.sub.6, L is C.sub.1-3 alkylene.